Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag on the page updated from v3.5.4 to v3.5.5. This reflects a minor update to the page or site template.
    Difference
    0.1%
    Check dated 2026-06-05T12:57:27.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, reflecting a new metadata version for the page. No content or functionality changes are introduced.
    Difference
    0.1%
    Check dated 2026-05-15T03:25:57.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor website/version update rather than any change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-23T21:56:02.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed.
    Difference
    0.1%
    Check dated 2026-04-16T12:22:50.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:19:36.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:41:38.000Z thumbnail image

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.